Singapore markets closed
  • Straits Times Index

    3,157.97
    -4.53 (-0.14%)
     
  • Nikkei

    28,948.73
    -9.83 (-0.03%)
     
  • Hang Seng

    28,842.13
    +103.25 (+0.36%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • BTC-USD

    35,581.61
    -1,545.06 (-4.16%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • Dow

    34,479.60
    +13.36 (+0.04%)
     
  • Nasdaq

    14,069.42
    +49.09 (+0.35%)
     
  • Gold

    1,879.50
    -16.90 (-0.89%)
     
  • Crude Oil

    70.78
    +0.49 (+0.70%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • FTSE Bursa Malaysia

    1,575.16
    -4.74 (-0.30%)
     
  • Jakarta Composite Index

    6,095.50
    -12.04 (-0.20%)
     
  • PSE Index

    6,907.79
    +32.08 (+0.47%)
     

Global Migraine Epidemiology and Patient Flow Analysis Report 2020-2035

·2-min read

Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Global Migraine Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Migraine Epidemiology and Patient Flow Analysis - 2021, provides Migraine epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Migraine patients, history of the disease at the population level (Migraine prevalence, Migraine incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Migraine patient flow: Migraine prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Migraine patients by age group, gender

  • Forecast: Migraine epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Migraine market sizing, assessing market potential, and developing drug forecast models

  • Identify Migraine patients segments through age groups, gender, and disease sub-types

  • Develop Migraine population-based health management frameworks

  • Evaluate Migraine market opportunities, identify target patient population

  • Align marketing decisions with the Migraine target population

  • Communicate leadership and health authorities about your Migraine target patient population

Key Topics Covered:

1. Research Methodology

2. Migraine Patients Definition

3. US Migraine Epidemiology and Patient Flow

4. Germany Migraine Epidemiology and Patient Flow

5. France Migraine Epidemiology and Patient Flow

6. Italy Migraine Epidemiology and Patient Flow

7. Spain Migraine Epidemiology and Patient Flow

8. UK Migraine Epidemiology and Patient Flow

9. Europe Migraine Epidemiology and Patient Flow

10. Japan Migraine Epidemiology and Patient Flow

11. Global Migraine Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/uwiytl

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900